MATTHEW STINSON: Open Payments
NPI 1972510618 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 17 payments from 9 companies in 2025. Trend: 2023 $66 · 2024 $338 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Nalu Medical, Inc. | 6 | $630 |
| Valinor Pharma, LLC | 3 | $46 |
| Boston Scientific Corporation | 2 | $44 |
| Tanabe Pharma America, Inc. | 1 | $31 |
| TG Therapeutics, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| SpringWorks Therapeutics, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: Nalu Neurostimulation System, MOVANTIK, WaveWriter Alpha Prime 16, Radicava, BRIUMVI, PONVORY, JOURNAVX, XTAMPZA.
Industry payments across IN — which companies pay providers there.
